SCHEMBL3919616

SCHEMBL3919616

C=CCO/C(C(=O)OCC)=C(/O)CC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 1/20 0.36
GLO1 Q04760 1/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
CYP2D6 P10635 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SOAT1 P35610 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
MAPT P10636 3/20 0.33
CYP3A4 P08684 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
PKM P14618 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3919618 1.00 TSHR (0.39) TSHRNPSR1GLO1ALDH1A1SMN1; SMN2
SCHEMBL16843451 0.80 TSHR (0.40) TSHRNPSR1GLO1ALDH1A1SMN1; SMN2
SCHEMBL3930383 0.78 GLO1 (0.37) TSHRNPSR1GLO1ALDH1A1SMN1; SMN2
SCHEMBL3930385 0.78 GLO1 (0.37) TSHRNPSR1GLO1ALDH1A1SMN1; SMN2
SCHEMBL28992610 0.74 TSHR (0.41) TSHRGLO1ALDH1A1SMN1; SMN2MAPT
SCHEMBL1245485 0.73 ALDH1A1 (0.44) TSHRNPSR1GLO1ALDH1A1SMN1; SMN2
SCHEMBL17960733 0.73 ALDH1A1 (0.44) TSHRNPSR1GLO1ALDH1A1SMN1; SMN2
Ammonia Solution, Strong SCHEMBL10984206 0.73 TSHR (0.40) TSHRALDH1A1SMN1; SMN2MAPTCYP3A4
Bicarbonate SCHEMBL25420518 0.71 ALDH1A1 (0.56) TSHRNPSR1ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL7096132 0.71 SOAT1 (0.65) TSHRNPSR1ALDH1A1SMN1; SMN2SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550607-B2 Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses AUSPEX PHARMACEUTICAL, INC. (US) 2009-06-23 US disclosed
US-20060173199-A1 Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses HONG BORCHERNG 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173199-A1 Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses LSS, DHPS, CYP51A1 TSHR 3358/4885NPSR1 1764/4885GLO1 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.